Autologous bone marrow transplantation in poor-risk high-grade non-Hodgkin's lymphoma in first complete remission. Newcastle and Northern Lymphoma Group.

We report the safety and efficacy of autologous bone marrow transplantation (ABMT) in 30 patients with high-grade non-Hodgkin's lymphoma (NHL) in first complete remission (CR1) following remission induction chemotherapy. Two patients relapsed prior to ABMT. All patients were conditioned with hi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jackson, G. H., Lennard, A. L., Taylor, P. R., Carey, P., Angus, B., Lucraft, H., Evans, R. G., Proctor, S. J.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1994
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033362/
https://www.ncbi.nlm.nih.gov/pubmed/7521662

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033362/
https://www.ncbi.nlm.nih.gov/pubmed/7521662

Ejemplares similares